- Home
- SXTP vs BDRX Comparison
SXTP vs BDRX Comparison
Compare SXTP & BDRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SXTP
- BDRX
- Stock Information
- Founded
- SXTP 2010
- BDRX 2000
- Country
- SXTP United States
- BDRX United Kingdom
- Employees
- SXTP N/A
- BDRX N/A
- Industry
- SXTP Biotechnology: Pharmaceutical Preparations
- BDRX Biotechnology: Pharmaceutical Preparations
- Sector
- SXTP Health Care
- BDRX Health Care
- Exchange
- SXTP Nasdaq
- BDRX Nasdaq
- Market Cap
- SXTP 3.7M
- BDRX 3.2M
- IPO Year
- SXTP 2023
- BDRX N/A
- Fundamental
- Price
- SXTP $0.98
- BDRX $3.96
- Analyst Decision
- SXTP Strong Buy
- BDRX
- Analyst Count
- SXTP 3
- BDRX 0
- Target Price
- SXTP $4.50
- BDRX N/A
- AVG Volume (30 Days)
- SXTP 61.3K
- BDRX 175.1K
- Earning Date
- SXTP 11-13-2025
- BDRX 09-12-2025
- Dividend Yield
- SXTP N/A
- BDRX N/A
- EPS Growth
- SXTP N/A
- BDRX N/A
- EPS
- SXTP N/A
- BDRX N/A
- Revenue
- SXTP $1,364,945.00
- BDRX N/A
- Revenue This Year
- SXTP $81.41
- BDRX N/A
- Revenue Next Year
- SXTP $83.17
- BDRX N/A
- P/E Ratio
- SXTP N/A
- BDRX N/A
- Revenue Growth
- SXTP 202.10
- BDRX N/A
- 52 Week Low
- SXTP $0.85
- BDRX $3.58
- 52 Week High
- SXTP $12.45
- BDRX $92.00
- Technical
- Relative Strength Index (RSI)
- SXTP 31.86
- BDRX 35.26
- Support Level
- SXTP $0.97
- BDRX $3.58
- Resistance Level
- SXTP $1.08
- BDRX $5.74
- Average True Range (ATR)
- SXTP 0.09
- BDRX 0.49
- MACD
- SXTP -0.02
- BDRX -0.14
- Stochastic Oscillator
- SXTP 31.55
- BDRX 27.63
About SXTP 60 Degrees Pharmaceuticals Inc.
60 Degrees Pharmaceuticals Inc operates as a specialty pharmaceutical company with the goal of using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases. The firm's pipeline products under development cover development programs for COVID-19, fungal, tick-borne, and other viral diseases.
About BDRX Biodexa Pharmaceuticals plc
Biodexa Pharmaceuticals PLC is a clinical-stage biopharmaceutical company focused on developing a pipeline of products to treat diseases that have unmet medical needs. These include familial adenomatous polyposis (FAP), non-muscle invasive bladder cancer (NMIBC), type 1 diabetes (T1D), and rare or orphan brain cancers.